HYBRID EVENT: You can participate in person at Rome, Italy or Virtually from your home or work.
Speaker at Pharma Conferences - John K Maesaka
Keynote Presentation
John K Maesaka, NYU Long Island School of Medicine, United States

The approach to hyponatremia is in a state of flux, especially in differentiating the syndrome of inappropriate secretion of antidiuretic hormone (SIADH) from cerebral-renal salt wasting (RSW) because of diametrically opposite therapeutic goals of water-restricting in SIADH and a [....] » Read More

Speaker at Pharmaceutical Conference - Bartolome Ribas Ozonas
Keynote Presentation
Bartolome Ribas Ozonas, Royal National Academy of Pharmacy, Spain

The blood-brain barrier protects the brain from certain ions, molecules and medicaments from their action and toxicity like the clouds in the earth's biosphere and its climate. Our thoughts induce neuron stimulation through synaptic activity, chemical reactions, electron move [....] » Read More

Speaker at Pharmaceutical Conference - Richard Denk
Keynote Presentation
Richard Denk, SKAN AG, Switzerland

The new EU GMP Annex 1 for sterile Manufacturing was published in August 2022. The industry does now have one year's time for implementation. Exception loading and unloading for the Lyophilization which provides an implementation time of two years. What does this mean for ste [....] » Read More

Speaker at Pharmaceutical Conference - Andreia Freitas
Keynote Presentation
Andreia Freitas, INIAV and REQUIMTE, Portugal

The constant release of veterinary and human pharmaceutical drugs as active compounds or metabolites to the environment can result in the presence of undesirable contaminants in the ecosystems. Such anthropogenic contaminants can be discharged into the environment through wastewa [....] » Read More

Speaker at Pharma Conferences - Mujde Eryilmaz
Keynote Presentation
Mujde Eryilmaz, Ankara University, Turkey

Antibiotics are essential and versatile drugs due to the necessity of their use in cases such as surgical procedures, organ transplantations, and the treatment of cancer patients. However, due to the increasing rates of antibiotic resistance in recent years, there has been a fail [....] » Read More

Speaker at Pharmaceutical Conference - Aysu selcuk
Keynote Presentation
Aysu selcuk, Ankara University, Turkey

The outbreak of coronavirus disease 2019 increased the use of technology, especially in the healthcare sector, which experienced enormous pressures to provide for patients’ health needs. Due to the outbreak measures such as physical distancing or self-isolation, many patien [....] » Read More

Speaker at Pharma Conferences - Wayne Kaesemeyer
Oral Presentation
Wayne Kaesemeyer, Augusta Hypertension PC, United States

This presentation will focus on the NLRP3 inflammasome and its involvement in the pathogenesis of cardiovascular diseases, the causes of its activation, and approaches to targeting these causes based on an extrapolation of the mechanism for preventing nitroglycerin tolerance usin [....] » Read More

Speaker at Pharma Conferences - Gurpreet Singh
Oral Presentation
Gurpreet Singh, IQVIA, United Kingdom

Pharmacovigilance is the Detection, Assessment, Understanding and Prevention of Adverse Events associates with Drugs. Over the last 2 decades there has been an increased focus on Pharmacovigilance in order to ensure Patient Safety. The Health Authority requirements for a Marketin [....] » Read More

Speaker at Drug Delivery Events - Liberata Sportiello
Oral Presentation
Liberata Sportiello, University of Campania “L. Vanvitelli”, Italy

Although the European Medicines Agency (EMA) encourages coronavirus disease 2019 (COVID-19) vaccination in pregnant women, the scientific evidence supporting the use of COVID-19 vaccines during pregnancy is still limited. Thus, we investigated adverse events following immunizatio [....] » Read More

Speaker at Drug Delivery Events - Nikolay E. Polyakov
Oral Presentation
Nikolay E. Polyakov, Voevodsky Institute of Chemical Kinetics and Combustion, Russian Federation

Electron transfer plays a critical role in the generation of reactive oxygen species (ROS) in living systems. Molecular oxygen acts as a terminal electron acceptor in the respiratory chains of aerobic organisms, as well as in some photoinduced processes with subsequent formation [....] » Read More

Speaker at Drug Delivery Events - Ashtavaidyan Dr. E.T. Krishnan Mooss
Oral Presentation
Ashtavaidyan Dr. E.T. Krishnan Mooss, Vaidyaratnam Group, India

Ayurveda is a traditional healthcare system of Indian medicine since ancient times. Several drugs have been developed and practiced from Ayurveda since ancient times to modern practice as ‘tradition to trend’. Charaka Samhita, Sushruta Samhita (~400 BC–200  [....] » Read More

Speaker at Pharmaceutical Conference - Asit Kumar Chakraborty
Oral Presentation
Asit Kumar Chakraborty, Vidyasagar University, India

Alpha and Delta coronaviruses spread worldwide claiming >634000 lives and secondary multidrug-resistant infections were found a risk factor specifically in ICU patients containing carbapenem-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, Enterococcus faecium and Kl [....] » Read More

Speaker at Pharma Conferences - Rajesh Kumar
Oral Presentation
Rajesh Kumar, B.R.A. Bihar University, India

Over two decades, a large number of nucleosides have been synthesized, which demonstrated potent antiviral and antitumor activities and have become cornerstones of treatment for patients with cancer or viral infections. Oligonucleotide-based antisense strategies represent a uniqu [....] » Read More

Speaker at Pharma Conferences - Eman Ramadan Abbase
Oral Presentation
Eman Ramadan Abbase, Helwan University, Egypt

The permeability of the liposomal membrane is an important factor in determining whether drugs encapsulated inside liposomes are released. Many studies revealed the role of thermotropic phase, saturation degree and acyl chain length for the permeability of the liposomal membrane. [....] » Read More

Speaker at Pharma Conferences - Kalirajan Rajagopal
Oral Presentation
Kalirajan Rajagopal, JSS college of pharmacy, India

Since 2020, COVID?19 has created a major threat to the human population across the globe. There are many mutations in SARS CoV-2 like Alpha, Beta, Delta and Omicron, etc. A newly emerged SARS-CoV-2 variant B.1.1.529 has worried health policymakers worldwide due to the presence of [....] » Read More

Speaker at Drug Delivery Events -  Andreas M Papas
Oral Presentation
Andreas M Papas, Antares Health Products, United States

Vitamin E TPGS (d-α-tocopheryl polyethylene glycol 1000 succinate) combines the functions of solubilizer, emulsifier, and absorption enhancer of lipophilic and poorly soluble drugs. In addition, it enhances drug bioavailability and efficacy through inhibition of the P-glyco [....] » Read More

Speaker at Pharmaceutical Conference - Andrea Stierle
Oral Presentation
Andrea Stierle, University of Montana, United States

According to the CDC, at least two million people are infected with antibiotic-resistant bacteria every year, and over 35,000 die annually as a direct result of these infections. The Infectious Disease Society of America published a policy report that outlined the consequences of [....] » Read More

Speaker at Drug Delivery Events -  Ali Yetgin
Oral Presentation
Ali Yetgin, Institute of Nature and Applied Sciences, Department of Biotechnology, Adana, Turkey, Turkey

Plants have played a pivotal role in the realm of contemporary drug discovery and screening, serving as a vast source of diverse and bioactive compounds. The present study thoroughly examines the multifarious contributions of plants to the progression of pharmaceutical research a [....] » Read More

Speaker at Drug Delivery Events - Juan Gu
Oral Presentation
Juan Gu, Affiliated Hospital of Zunyi Medical University, China

Short Description of what will be discussed during the presentation (about 250 - 500 words)My presentation will be divided into three parts. Firstly, I aim to introduce the background of potentially inappropriate medicines and highlight the pertinent problem that requires resolut [....] » Read More

Speaker at Drug Delivery Events -  Nikola Matejkova
Oral Presentation
Nikola Matejkova, University of Pardubice, Czech Republic

Hyaluronic acid (HA) is a naturally occurring long linear polysaccharide known for its biocompatibility, biodegradability, and non-immunogenicity. Nanoparticles from hyaluronic acid have great potential as drug delivery carriers of chemotherapeutics and other biomolecules. The ro [....] » Read More

Speaker at Pharma Conferences - Franz Josef Meyer Almes
Oral Presentation
Franz Josef Meyer Almes, University of Applied Sciences, Germany

Compounds with a thiazolidinedione (TZD) functionality, so called glitazones, are known as PPAR?-activators and anti-diabetic drugs. The mode of action of these glitazones has extensively be investigated and is known in great structural details. PPAR? is a prominent target with [....] » Read More

Speaker at Drug Delivery Events - Danuta Drozdowska
Poster Presentation
Danuta Drozdowska, Medical University of Bialystok, Poland

Designing, synthesize and developing of novel bioactive molecules is the crucial role of medicinal chemistry. The concept of drug design and development, called multi-target directed ligand (MTDL), multiple ligand strategy (MLS) or designed multiple ligands (DMLs), is an innovati [....] » Read More

Speaker at Drug Delivery Events - Ernst Wagner
Keynote Presentation
Ernst Wagner, Ludwig-Maximilians-Universitat Munich, Germany

Twenty two RNA therapies reached the medical market by Q1 2023. Targeted intracellular delivery remains the key requirement. For refinements of nanocarriers we focus on a bioinspired, sequence-defined process including (i) artificial amino acids (ii) precise assembly into xenopep [....] » Read More

Speaker at Pharmaceutical Conference - Thomas J. Webster
Keynote Presentation
Thomas J. Webster, Mansfield Bioincubator, United States

Nanomaterials have been widely tested in vitro and in small-order animal studies for decades. Results have shown greater tissue growth, decreased bacteria growth, and inhibited inflammation. However, few studies exist examining human tissue response to nanomaterials. This present [....] » Read More

Speaker at Pharma Conferences - Luis Jesus Villarreal Gomez
Keynote Presentation
Luis Jesus Villarreal Gomez, FCITEC - Universidad Autónoma de Baja California, Mexico

The necessity of new systems for drug delivery in children is due to the difficulty of the correct dose administration when the drug carrier is not easy to administrate. Mucoadhesive electrospun fibrous systems are an interesting alternative for the treatment of pathologies in th [....] » Read More

Speaker at Pharma Conferences - Anna Weronika Sobanska
Keynote Presentation
Anna Weronika Sobanska, Medical University of Lodz, Poland

Novel Quantitative Structure-Activity Relationship (QSAR) models of compounds’ placenta (PL) permeability expressed as their: i) log FM (fetus-to-mother blood concentration) values; ii) Clearance Index (CI); iii) binary PL1/0 (crossing/non-crossing; Yes/No) score were gener [....] » Read More

Speaker at Drug Delivery Events - Noemi Rotllan Vila
Keynote Presentation
Noemi Rotllan Vila, IIB SANT PAU and CIBERDEM, Spain

It is known that several microRNAs (miRNAs) have an important regulatory role during the different stages of atheroma plaque formation. In preclinical studies, the regulation of its expression has been shown beneficial outputs in the treatment of atherosclerosis. Thus, the therap [....] » Read More

Speaker at Drug Delivery Events - Miroslav Radenkovic
Keynote Presentation
Miroslav Radenkovic, University of Belgrade, Serbia

Diabetes mellitus represents a large-scale health concern and has become a distressing hazard in the modern epoch of compromised lifestyles. So, there is an imperative need for screening and developing new pharmacologically active compounds that can meet still existing insufficie [....] » Read More

Speaker at Drug Delivery Events - Delia Teresa Sponza
Oral Presentation
Delia Teresa Sponza, Dokuz Eylul University, Turkey

Tetracyclines (TC) are a class of broad-spectrum antibiotics widely employed to treat various human and animal bacterial infections. Due to their incomplete adsorption and partial metabolization by humans and animals, more than 70% of the TC used for pharmacological treatment are [....] » Read More

Speaker at Pharmaceutical Conference - Mario Souza Y Machorro
Oral Presentation
Mario Souza Y Machorro, International College of Superior Education, Mexico

The text reviews a health issue through its epidemiological scope; Points out: chemical structure, synthesis, and mechanisms of action; It discusses its potency and speed of action, forms of administration and interaction with other drugs; Instructs on medical use; It recommend [....] » Read More

Speaker at Pharma Conferences - Preeti Sharma
Oral Presentation
Preeti Sharma, Autonomous State Government Medical College, India

Background: Cancer is a major cause of morbidity and mortality worldwide. Small heterocyclic molecules are promising anti-cancer molecules. Imidazoquinoxaline derivatives induce apoptosis in colon cancer cell line HCT-116 and Breast cancer cell line MDA-MB-231. Aim: Investigat [....] » Read More

Speaker at Drug Delivery Events - Ravi P. Sahu
Oral Presentation
Ravi P. Sahu, Wright State University, United States

Chemotherapy has remained the mainstay for the treatment of multiple types of cancers. In particular, topical use of chemotherapy has been used for skin cancers. Though effective, topical chemotherapy has been limited due to adverse effects such as local and even systemic toxicit [....] » Read More

Speaker at Pharma Conferences - Richard Z. Cheng
Oral Presentation
Richard Z. Cheng, Cheng Integrative Health Center, United States

Cytokine storm has recently been recognized as the key pathology responsible for the severe symptoms of Covid-19 and other viruses and non-viral agents. The underlying biochemical cause of cytokine storms is excessive oxidative stress. Cytokine storm and its associated oxidative [....] » Read More

Speaker at Drug Delivery Events - Vandana B. Patravale
Oral Presentation
Vandana B. Patravale, Institute of Chemical Technology, India

Peptide-based therapeutics, in the current biopharmaceutical market, are majorly available as parenteral formulations. Inherent physicochemical properties of peptides including hydrophilicity, bulky size, enzymatic degradation, and stress-induced denaturation make their delivery [....] » Read More

Speaker at Pharma Conferences - Suresh P.K
Oral Presentation
Suresh P.K, VIT University, India

Based on the current and future market trends, liposome-based drug delivery systems is expected to have a phenomenal market size of 10 billion US dollars by the year 2035.  The market potential has culminated in the synthesis and characterization of several liposomal product [....] » Read More

Speaker at Pharmaceutical Conference - Rudra Pratap Singh Rajput
Oral Presentation
Rudra Pratap Singh Rajput, Royal College of Pharmacy, India

Background: Coronaviruses are a family of viruses that can cause illnesses such as the common cold, Fever, severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), Cancer, Asthma etc.Respiratory infection (RTI) is a viral spreading disease and it transmi [....] » Read More

Speaker at Pharmaceutical Conference - Geetanjali Sageena
Oral Presentation
Geetanjali Sageena, Indian Council of Medical Research, India

While AI technologies are rapidly developing in medicine, their implementation in daily care is not yet a reality and we should not be overwhelmed by the challenges we face, but instead use resources to develop AI concepts in pharmacogenomic therapies, to make them safer and more [....] » Read More

Speaker at Pharmaceutical Conference - Tarek Aboul Fadl
Oral Presentation
Tarek Aboul Fadl, Assiut University, Egypt

Cancer remains a global public health concern due to its morbidity and mortality, and anticancer agents are crucial for the control and eradication of cancers. According to the International Agency for Research on Cancer. Although cancer chemotherapy has progressed in major strid [....] » Read More

Speaker at Pharmaceutical Conference - Maria Borrell
Oral Presentation
Maria Borrell, IR Hospital de Sant Pau, Spain

Atherosclerosis, the leading cause of cardiovascular diseases, is driven by high blood cholesterol levels and chronic inflammation. The disruption of the hepatic interaction between Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) and Low-Density Lipoprotein Receptor (LDLR) downr [....] » Read More

Speaker at Pharma Conferences - Zinnet Şevval Aksoyalp
Oral Presentation
Zinnet Şevval Aksoyalp, Izmir Katip Celebi University, Turkey

Pharmaceutical waste constitutes a significant environmental challenge, with millions of dollars worth of unused medications being discarded annually. The mismanagement of pharmaceutical waste not only poses a critical ecological problem but also imposes a substantial global econ [....] » Read More

Speaker at Pharma Conferences - Saad Tayyab
Oral Presentation
Saad Tayyab, UCSI University, Malaysia

Hepatitis B, a viral infection that can cause both acute and chronic hepatitis, cirrhosis and hepatocellular carcinoma, is a major global health issue. Hepatocellular carcinoma is one of the most common types of cancer, accounting for roughly 90% of all primary liver tumours. &nb [....] » Read More

Speaker at Pharmaceutical Conference - Panagiotis Mallis
Oral Presentation
Panagiotis Mallis, Biomedical Research Foundation Academy of Athens, Greece

Background: Accumulated evidence has emerged on the role of stem cells in key cellular functions such as their implication in host immune response and tissue regeneration. Currently, Mesenchymal Stromal Cells (MSCs), which are multipotent stem cells, have been used in a grea [....] » Read More